Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Pre/Post Pilot Test of Video Module Education

Not Applicable

Completed

Conditions: Asthma
Chronic Obstructive Pulmonary Disease

Interventions: Behavioral: VME Group

First Posted Date: 2014-10-29

Last Posted Date: 2019-06-04

Lead Sponsor: University of Chicago

Target Recruit Count: 90

Registration Number: NCT02278237

Pilot Study of Novel Postpartum Educational Video Intervention

Not Applicable

Completed

Conditions: Language
Behavior
Communication

Interventions: Other: Safe Sleep for your Baby (SIDS) educational video
Other: TMW-Newborn Intervention video

First Posted Date: 2014-10-17

Last Posted Date: 2017-12-06

Lead Sponsor: University of Chicago

Target Recruit Count: 694

Registration Number: NCT02267265

Locations: 🇺🇸
The University of Chicago Medicine, Chicago, Illinois, United States
🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States

Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer

Phase 2

Active, not recruiting

Conditions: Human Papilloma Virus Infection
Stage III Squamous Cell Carcinoma of the Oropharynx
Stage IVA Squamous Cell Carcinoma of the Oropharynx
Stage IVB Squamous Cell Carcinoma of the Oropharynx

Interventions: Drug: paclitaxel albumin-stabilized nanoparticle formulation
Drug: carboplatin
Radiation: radiation therapy
Other: laboratory biomarker analysis
Drug: paclitaxel
Procedure: quality-of-life assessment
Drug: fluorouracil
Drug: hydroxyurea
Drug: cisplatin

First Posted Date: 2014-10-07

Last Posted Date: 2023-09-18

Lead Sponsor: University of Chicago

Target Recruit Count: 62

Registration Number: NCT02258659

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Home Sleep and Metabolism

Not Applicable

Completed

Conditions: Overweight
Sleep

Interventions: Other: sleep

First Posted Date: 2014-10-01

Last Posted Date: 2021-02-05

Lead Sponsor: University of Chicago

Target Recruit Count: 210

Registration Number: NCT02253368

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Thirty Million Words Home Visiting

Not Applicable

Active, not recruiting

Conditions: Language Environments of Children of Low-socioeconomic Status

Interventions: Other: TMW Curriculum
Other: Nutrition Curriculum

First Posted Date: 2014-08-13

Last Posted Date: 2025-03-07

Lead Sponsor: University of Chicago

Target Recruit Count: 206

Registration Number: NCT02216032

Locations: 🇺🇸
Thirty Million Words® Initiative at the University of Chicago Medicine, Chicago, Illinois, United States

Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas

Phase 1

Active, not recruiting

Conditions: Adult Grade III Lymphomatoid Granulomatosis
B-cell Chronic Lymphocytic Leukemia
Contiguous Stage II Adult Diffuse Large Cell Lymphoma
Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma
Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma
Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma
Contiguous Stage II Grade 1 Follicular Lymphoma
Contiguous Stage II Grade 2 Follicular Lymphoma
Contiguous Stage II Grade 3 Follicular Lymphoma
Contiguous Stage II Mantle Cell Lymphoma

Interventions: Drug: lenalidomide
Drug: etoposide
Drug: prednisone
Drug: vincristine sulfate
Drug: doxorubicin hydrochloride
Drug: cyclophosphamide
Biological: rituximab
Other: quality-of-life assessment
Other: laboratory biomarker analysis

First Posted Date: 2014-08-12

Last Posted Date: 2023-04-28

Lead Sponsor: University of Chicago

Target Recruit Count: 46

Registration Number: NCT02213913

Locations: 🇺🇸
NorthShore University HealthSystem, Evanston, Illinois, United States
🇺🇸
Decatur Memorial Hospital Cancer Care Institute, Decatur, Illinois, United States
🇺🇸
Illinois Cancer Care, Peoria, Illinois, United States

and more 3 locations

PANGEA-IMBBP: Personalized Antibodies for Gastro-Esophageal Adenocarcinoma - A 1st Pilot Metastatic Trial of Biologics Beyond Progression

Phase 2

Completed

Conditions: Adenocarcinoma

Interventions: Drug: Ramucirumab
Drug: ABT-806
Drug: Trastuzumab
Drug: Nivolumab
Drug: Bemarituzumab
Drug: Standard cytotherapy

First Posted Date: 2014-08-11

Last Posted Date: 2021-04-08

Lead Sponsor: University of Chicago

Target Recruit Count: 80

Registration Number: NCT02213289

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

The Effects of Hydromorphone on Responses to Verbal Tasks

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: 2 mg hydromorphone
Drug: 4 mg hydromorphone
Drug: 1000 mg Acetaminophen
Drug: dextrose

First Posted Date: 2014-08-01

Last Posted Date: 2018-10-09

Lead Sponsor: University of Chicago

Target Recruit Count: 50

Registration Number: NCT02205983

Locations: 🇺🇸
University of Chicago Hospital, Chicago, Illinois, United States

Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy

Not Applicable

Completed

Conditions: Thyroid Neoplasms
Goiter, Nodular
Thyroid Nodule
Graves' Disease
Hyperparathyroidism

Interventions: Procedure: Superficial Cervical Plexus Block
Procedure: Local Wound Infiltration
Drug: Marcaine
Drug: 0.9% saline

First Posted Date: 2014-07-31

Last Posted Date: 2018-03-09

Lead Sponsor: University of Chicago

Target Recruit Count: 36

Registration Number: NCT02205801

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 1

Recruiting

Conditions: Refractory Multiple Myeloma

Interventions: Drug: selinexor
Drug: carfilzomib
Drug: dexamethasone

First Posted Date: 2014-07-24

Last Posted Date: 2024-11-22

Lead Sponsor: University of Chicago

Target Recruit Count: 100

Registration Number: NCT02199665

Locations: 🇺🇸
Mount Sinai Medical Center, New York, New York, United States
🇺🇸
Mayo Clinic (AZ), Scottsdale, Arizona, United States
🇺🇸
Wayne State University Karmanos Cancer Institute, Detroit, Michigan, United States

and more 2 locations

Home Terms & Conditions Privacy Policy